Mittal R, Debs LH, Patel AP, Nguyen D, Patel K, O’Connor G, et al. Neurotransmitters: the critical modulators regulating gut-brain axis. J Cell Physiol. 2017;232:2359–72.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Agirman G, Yu KB, Hsiao EY. Signaling inflammation across the gut-brain axis. Science. 2021;374:1087–92.

CAS  PubMed  Article  Google Scholar 

Catalá-López F, Suárez-Pinilla M, Suárez-Pinilla P, Valderas JM, Gómez-Beneyto M, Martinez S, et al. Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies. Psychother Psychosom. 2014;83:89–105.

PubMed  Article  Google Scholar 

Feng DD, Cai W, Chen X. The associations between Parkinson’s disease and cancer: the plot thickens. Transl Neurodegener. 2015;4:20.

PubMed  PubMed Central  Article  Google Scholar 

Ejma M, Madetko N, Brzecka A, Guranski K, Alster P, Misiuk-Hojło M, et al. The links between Parkinson’s disease and cancer. Biomedicines. 2020;8:416.

CAS  PubMed Central  Article  Google Scholar 

Jiang S-H, Hu L-P, Wang X, Li J, Zhang Z-G. Neurotransmitters: emerging targets in cancer. Oncogene. 2020;39:503–15.

CAS  PubMed  Article  Google Scholar 

Furness JB. The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol. 2012;9:286–94.

CAS  PubMed  Article  Google Scholar 

Tait C, Sayuk GS. The brain-gut-microbiotal axis: a framework for understanding functional GI illness and their therapeutic interventions. Eur J Intern Med. 2021;84:1–9.

PubMed  Article  Google Scholar 

Margolis KG, Cryan JF, Mayer EA. The microbiota-gut-brain axis: from motility to mood. Gastroenterology. 2021;160:1486–501.

CAS  PubMed  Article  Google Scholar 

Schledwitz A, Xie G, Raufman JP. Exploiting unique features of the gut-brain interface to combat gastrointestinal cancer. J Clin Investig. 2021;131:e143776.

CAS  PubMed Central  Article  Google Scholar 

Lutgendorf SK, Sood AK. Biobehavioral factors and cancer progression: physiological pathways and mechanisms. Psychosom Med. 2011;73:724–30.

PubMed  PubMed Central  Article  Google Scholar 

Tatsuta M, Iishi H, Baba M, Taniguchi H. Inhibition of azoxymethane-induced experimental colon carcinogenesis in Wistar rats by 6-hydroxydopamine. Int J Cancer. 1992;50:298–301.

CAS  PubMed  Article  Google Scholar 

Sadighparvar S, Darband SG, Ghaderi-Pakdel F, Mihanfar A, Majidinia M. Parasympathetic, but not sympathetic denervation, suppressed colorectal cancer progression. Eur J Pharmacol. 2021;913:174626.

CAS  PubMed  Article  Google Scholar 

Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiol Rev. 1998;78:189–225.

CAS  PubMed  Article  Google Scholar 

Penedo MA, Rivera-Baltanás T, Pérez-Rodríguez D, Allen J, Borrajo A, Alonso-Crespo D, et al. The role of dopamine receptors in lymphocytes and their changes in schizophrenia. Brain Behav Immun Health. 2021;12:100199.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev. 2011;63:182–217.

CAS  PubMed  Article  Google Scholar 

Beaulieu JM, Espinoza S, Gainetdinov RR. Dopamine receptors—IUPHAR -review 13. Br J Pharm. 2015;172:1–23.

CAS  Article  Google Scholar 

Grant CE, Flis AL, Ryan BM. Understanding the role of dopamine in cancer: past, present and future. Carcinogenesis. 2022;43:517–27.

PubMed  Article  Google Scholar 

Leng ZG, Lin SJ, Wu ZR, Guo YH, Cai L, Shang HB, et al. Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death. Autophagy. 2017;13:1404–19.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Kontos CK, Papadopoulos IN, Fragoulis EG, Scorilas A. Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma. Br J Cancer. 2010;102:1384–90.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Gemignani F, Landi S, Moreno V, Gioia-Patricola L, Chabrier A, Guino E, et al. Polymorphisms of the dopamine receptor gene DRD2 and colorectal cancer risk. Cancer Epidemiol Biomark Prev. 2005;14:1633–8.

CAS  Article  Google Scholar 

Battaglin F, Cao S, Loupakis F, Stintzing S, Parikh AR, Puccini A, et al. Polymorphisms in the dopamine (DA) signaling to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): data from TRIBE, MAVERICC, and FIRE-3 phase III trials. J Clin Oncol. 2019;37:3048.

Article  Google Scholar 

Sarkar C, Chakroborty D, Chowdhury UR, Dasgupta PS, Basu S. Dopamine increases the efficacy of anticancer drugs in breast and colon cancer preclinical models. Clin Cancer Res. 2008;14:2502–10.

CAS  PubMed  Article  Google Scholar 

Ren Y, Tao J, Jiang Z, Guo D, Tang J. Pimozide suppresses colorectal cancer via inhibition of Wnt/beta-catenin signaling pathway. Life Sci. 2018;209:267–73.

CAS  PubMed  Article  Google Scholar 

Lee H, Shim S, Kong JS, Kim MJ, Park S, Lee SS, et al. Overexpression of dopamine receptor D2 promotes colorectal cancer progression by activating the β-catenin/ZEB1 axis. Cancer Sci. 2021;112:3732–43.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Xia Y, Jia C, Xue Q, Jiang J, Xie Y, Wang R, et al. Antipsychotic drug trifluoperazine suppresses colorectal cancer by inducing G0/G1 arrest and apoptosis. Front Pharmacol. 2019;10:1029.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Tysnes OB, Storstein A. Epidemiology of Parkinson’s disease. J Neural Transm. 2017;124:901–5.

PubMed  Article  Google Scholar 

Deng H, Wang P, Jankovic J. The genetics of Parkinson disease. Ageing Res Rev. 2018;42:72–85.

CAS  PubMed  Article  Google Scholar 

Lee JYS, Ng JH, Saffari SE, Tan EK. Parkinson’s disease and cancer: a systematic review and meta-analysis on the influence of lifestyle habits, genetic variants, and gender. Aging. 2022;14:2148–73.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Fang H, Du Y, Pan S, Zhong M, Tang J. Patients with Parkinson’s disease predict a lower incidence of colorectal cancer. BMC Geriatr. 2021;21:564.

PubMed  PubMed Central  Article  Google Scholar 

Li W-H, Zhang H, Guo Q, Wu X-D, Xu Z-S, Dang C-X, et al. Detection of SNCA and FBN1 methylation in the stool as a biomarker for colorectal cancer. Dis Markers. 2015;2015:657570.

PubMed  PubMed Central  Article  Google Scholar 

Killinger BA, Madaj Z, Sikora JW, Rey N, Haas AJ, Vepa Y, et al. The vermiform appendix impacts the risk of developing Parkinson’s disease. Sci Transl Med. 2018;10:eaar5280.

PubMed  PubMed Central  Article  Google Scholar 

Battaglin F, Cao S, Puccini A, Tokunaga R, Naseem M, Arai H, et al. Gene expression and genetic variants in Parkinson’s disease (PD) genes to predict outcome in metastatic colorectal cancer (mCRC): data from FIRE-3 phase III trial. J Clin Oncol. 2019;37:3595.

Article  Google Scholar 

Bortolato M, Chen K, Shih JC. Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv Drug Deliv Rev. 2008;60:1527–33.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Yang YC, Chien MH, Lai TC, Su CY, Jan YH, Hsiao M, et al. Monoamine oxidase B expression correlates with a poor prognosis in colorectal cancer patients and is significantly associated with epithelial-to-mesenchymal transition-related gene signatures. Int J Mol Sci. 2020;21:2813.

PubMed Central  Article  Google Scholar 

Aljanabi R, Alsous L, Sabbah DA, Gul HI, Gul M, Bardaweel SK. Monoamine oxidase (MAO) as a potential target for anticancer drug design and development. Molecules. 2021;26:6019.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Wang Y-C, Wang X, Yu J, Ma F, Li Z, Zhou Y, et al. Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy. Nat Commun. 2021;12:3530.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Wang X, Li B, Kim YJ, Wang YC, Li Z, Yu J, et al. Targeting monoamine oxidase A for T cell-based cancer immunotherapy. Sci Immunol. 2021;6:eabh2383.

CAS  PubMed